IgG4‐Associated Autoimmune Hepatitis: a Systematic Review
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70213 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Chun-Hsun Liao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, Immunoglobulin G, Immunoglobulin G4-Related Disease. Die Arbeit nennt 58 Literaturangaben.
Abstract (Originalsprache)
Background
IgG4‐associated autoimmune hepatitis (IgG4‐AIH) is an emerging entity characterized by overlapping features of classical autoimmune hepatitis (AIH) and IgG4‐related disease (IgG4‐RD). However, significant heterogeneity in diagnostic criteria has obscured its true prevalence and clinical significance. This systematic review aimed to characterize the clinical, serological, and histopathological features of IgG4‐AIH.
Methods
Following PRISMA guidelines, a systematic search was conducted across PubMed, Embase, and Web of Science. Study selection, data extraction, and quality assessment using Joanna Briggs Institute (JBI) tools were performed independently by two reviewers. A narrative synthesis was conducted.
Results
A total of 43 studies (11 cohort studies, 32 case reports and series) describing 185 patients were included. The cohort was predominantly of Asian origin and showed a female predominance. The most common autoantibody was antinuclear antibody (73%–78%), while serum IgG4 levels were highly variable but exceeded the 135‐mg/dL threshold in all cases. Histopathologically, interface hepatitis and plasma cell infiltration were frequent features, and advanced fibrosis (Stages 3–4) was noted in approximately half the patients. Concurrent IgG4‐RD was significantly more prevalent in case‐based studies versus cohort studies (58% vs. 8.2%, respectively). Glucocorticoid therapy demonstrated high efficacy, with over 70% of patients achieving biochemical remission within three months.
Conclusion
This systematic review characterizes IgG4‐AIH as a distinct clinical entity bridging classical AIH and IgG4‐RD. Its unique clinical and pathological profile underscores the need for consensus diagnostic criteria and prospective studies to determine optimal management strategies and long‐term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Internal Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.
- Division of Chest, Department of Chest Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
- Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
ORCID-Profile: Chun-Hsun Liao, Tzu-Chan Hong, Jia-Horng Kao, Chun-Jen Liu
Zitieren
APA
Liao, C. H., Tseng, H. H., Shen, T. A., Hong, T. C., Hsu, S. J., Kao, J. H., & Liu, C. J. (2026). IgG4‐Associated Autoimmune Hepatitis: a Systematic Review. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70213
Vancouver
Liao CH, Tseng HH, Shen TA, Hong TC, Hsu SJ, Kao JH, et al. IgG4‐Associated Autoimmune Hepatitis: a Systematic Review. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70213
BibTeX
@article{Liao2026,
author = {Liao, Chun-Hsun and Tseng, Hsu-Hua and Shen, Ting-An and Hong, Tzu-Chan and Hsu, Shih-Jer and Kao, Jia-Horng and Liu, Chun-Jen},
title = {IgG4‐Associated Autoimmune Hepatitis: a Systematic Review},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70213}
}
EUVIMED